Science Market Update

UCSD Scientists Receive $8M to Research Leukemia Treatments

Posted by Laura Braden on Tue, Jan 02, 2018

Of the four main types of Leukemia, Acute Myeloid Leukemia (AML) diagnoses make up nearly one-third of new leukemia cases and is most likely to occur in adults. Although common cancer treatment methods are used for AML patients, only about half go into remission after chemotherapy treatments. Factors such as age and overall health contribute to these remission rates. Researchers at top life science institutions around the world continually study AML to gain better understandings of the biology of this cancer that can lead to new and more effect treatment methods. (Image courtesy Wikimedia Commons)

Read More

Tags: 2018, SDVS, Biotechnology Vendor Showcase, UCSD, cancer research, cancer research funding, new research funding, Leukemia, Acute Myeloid Leukemia, AML Research, CA, San Diego

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News